58 Companies in the Spotlight This Week – 1/31/15
We evaluated 58 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.
Gilead Sciences Inc. Annual Valuation – 2015 $GILD
Gilead Sciences Inc. is not suitable for either the Defensive Investor or the Enterprising Investor. The Defensive Investor is concerned with the lack of earnings stability over the last ten years, lack of dividend payments, and the high PEmg and PB ratios.
14 Companies in the Spotlight This Week – 1/18/14
We looked at 14 different companies this week.  Here’s a summary of the ModernGraham Valuations.  For more detailed analysis, click on the name of the company.  To see screens of all of our valuations, be sure to get a copy of this month’s edition of ModernGraham Stocks and Screens! The Elite (Defensive or Enterprising and Undervalued) […]